{{Rsnum
|rsid=210138
|Gene=BAK1
|Chromosome=6
|position=33574761
|Orientation=plus
|GMAF=0.241
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BAK1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 67.3 | 29.2 | 3.5
| HCB | 36.5 | 40.1 | 23.4
| JPT | 31.0 | 52.2 | 16.8
| YRI | 85.0 | 14.3 | 0.7
| ASW | 80.7 | 17.5 | 1.8
| CHB | 36.5 | 40.1 | 23.4
| CHD | 24.1 | 51.9 | 24.1
| GIH | 35.6 | 43.6 | 20.8
| LWK | 65.5 | 32.7 | 1.8
| MEX | 55.2 | 34.5 | 10.3
| MKK | 69.9 | 25.6 | 4.5
| TSI | 70.6 | 26.5 | 2.9
| HapMapRevision=28
}}
[http://blog.23andme.com/2009/06/02/snpwatch-genetic-variations-that-may-affect-testicular-cancer-risk-identified/ 23andMe blog] each rs210138(G) was found to increase the odds of [[testicular cancer]] by 1.5x

{{PMID Auto GWAS
|PMID=19483681
|Trait=Testicular germ cell tumor
|Title=A genome-wide association study of testicular germ cell tumor
|RiskAllele=G
|Pval=1E-13
|OR=1.50
|ORtxt=[1.28-1.75]
|OA=1
}}

{{omim
|id=273300
|rsnum=210138
}}

{{PMID Auto
|PMID=21617256
|Title=Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour
|OA=1
}}

{{PMID Auto
|PMID=22072546
|Title=Associations between variants in KITLG, SPRY4, BAK1, and DMRT1 and pediatric germ cell tumors.
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs210138
|overall_frequency_n=27
|overall_frequency_d=128
|overall_frequency=0.210938
|n_genomes=18
|n_genomes_annotated=0
|n_haplomes=22
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=2
|webscore=N
}}

{{PMID Auto GWAS
  |PMID=23666239
  |Trait=Testicular germ cell tumor
  |Title=Meta-analysis identifies four new loci associated with testicular germ cell tumor.
  |RiskAllele=G
  |Pval=3E-7
  |OR=1.62
  |ORtxt=[1.35-1.95]
  |OA=1
}}

{{PMID Auto GWAS
  |PMID=23666240
  |Trait=Testicular germ cell tumor
  |Title=Identification of nine new susceptibility loci for testicular cancer, including variants near DAZL and PRDM14.
  |RiskAllele=G
  |Pval=2E-24
  |OR=1.44
  |ORtxt=[1.30-1.61]
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}